The Cooper Cos. (NYSE:COO) EVP Albert G. White III sold 20,000 shares of The Cooper Cos. stock in a transaction dated Wednesday, September 14th. The shares were sold at an average price of $185.72, for a total transaction of $3,714,400.00. Following the completion of the sale, the executive vice president now owns 41,639 shares in the company, valued at $7,733,195.08. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

The Cooper Cos. (NYSE:COO) opened at 188.47 on Tuesday. The stock has a 50 day moving average of $184.37 and a 200 day moving average of $167.52. The firm has a market cap of $9.19 billion, a PE ratio of 36.90 and a beta of 0.20. The Cooper Cos. has a 52 week low of $119.28 and a 52 week high of $190.75.

The Cooper Cos. (NYSE:COO) last posted its earnings results on Thursday, September 1st. The medical device company reported $2.30 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.29 by $0.01. The Cooper Cos. had a net margin of 13.14% and a return on equity of 14.89%. The business had revenue of $514.70 million for the quarter. During the same period in the previous year, the company posted $1.97 EPS. The firm’s revenue for the quarter was up 11.5% compared to the same quarter last year. Analysts anticipate that The Cooper Cos. will post $8.43 EPS for the current year.

Several large investors have recently bought and sold shares of the company. BlackRock Inc. raised its stake in The Cooper Cos. by 1.7% in the first quarter. BlackRock Inc. now owns 110,074 shares of the medical device company’s stock valued at $16,947,000 after buying an additional 1,801 shares during the last quarter. Teachers Advisors Inc. raised its stake in The Cooper Cos. by 4.0% in the first quarter. Teachers Advisors Inc. now owns 43,148 shares of the medical device company’s stock valued at $6,643,000 after buying an additional 1,662 shares during the last quarter. TIAA CREF Investment Management LLC raised its stake in The Cooper Cos. by 10.0% in the first quarter. TIAA CREF Investment Management LLC now owns 138,100 shares of the medical device company’s stock valued at $21,263,000 after buying an additional 12,611 shares during the last quarter. Pacad Investment Ltd. purchased a new stake in The Cooper Cos. during the first quarter valued at $708,000. Finally, Torray LLC raised its stake in The Cooper Cos. by 55.4% in the first quarter. Torray LLC now owns 336,390 shares of the medical device company’s stock valued at $51,794,000 after buying an additional 119,875 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Several analysts recently weighed in on the stock. Stifel Nicolaus reiterated a “buy” rating and issued a $215.00 price objective on shares of The Cooper Cos. in a research report on Friday, September 9th. Jefferies Group lifted their price objective on shares of The Cooper Cos. from $190.00 to $210.00 and gave the company a “buy” rating in a research report on Wednesday, August 24th. BMO Capital Markets lifted their price objective on shares of The Cooper Cos. from $199.00 to $206.00 and gave the company an “outperform” rating in a research report on Friday, September 2nd. Wells Fargo & Co. reiterated a “hold” rating on shares of The Cooper Cos. in a research report on Sunday, September 11th. Finally, Zacks Investment Research downgraded shares of The Cooper Cos. from a “buy” rating to a “hold” rating in a research report on Friday, August 5th. Four investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $177.70.

The Cooper Cos. Company Profile

The Cooper Companies, Inc (Cooper) is a medical device company. The Company operates through two business units: CooperVision, Inc (CooperVision) and CooperSurgical, Inc (CooperSurgical). CooperVision develops, manufactures and markets a range of soft contact lenses for the vision correction market. CooperVision offers Biofinity monthly spherical, toric and multifocal lenses under the Avaira brand.

5 Day Chart for NYSE:COO

Receive News & Ratings for The Cooper Cos. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cooper Cos. and related companies with Analyst Ratings Network's FREE daily email newsletter.